November 18th 2021
A leading expert in lung cancer provides insights on recent data and review updates in the treatment landscape for patients with non-small-cell lung cancer and exon 20 insertions.
November 16th 2021
Dr Aaron Berger discusses recent advances in treatment and management of patients with nonmetastatic castrate-resistant prostate cancer.
October 18th 2021
Roy S. Herbst, MD, PhD, reviews currently available treatment options in immunotherapy in non-small-cell lung cancer and approaches to monitoring treatment response.
October 15th 2021
Oliver Sartor, MD, gives an overview of the use of PARP inhibitors to treat metastatic castration-resistant prostate cancer.
October 12th 2021
John Kirkwood, MD, PhD, discusses the use of immunotherapy as a treatment option for melanoma, including ctDNA, and how to properly monitor responses.
September 7th 2021
Connie Batlevi, MD, PhD, explains the treatment options for relapsed/refractory follicular lymphoma and discusses a recent drug approval.
July 6th 2021
Javier L. Munoz, MD, MS, FACP, explains the treatment options for relapsed/refractory follicular lymphoma and provides insight into a recent clinical trial.
June 28th 2021
Recommendations for utilizing genomic testing to aid in treatment decisions for early-stage HR+ breast cancer based on updates to the NCCN guidelines.
May 12th 2021
Sameh Gaballa, MD, reviews the treatment options for relapsed/refractory follicular lymphoma and future treatment options.